Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Status:
Terminated
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Personalized treatment approaches and antiplatelet drug choice have been proposed to optimize
safety of coronary stenting by reducing heart attacks and repeat interventions while
simultaneously minimizing adverse bleeding events. This study compares the efficacy of two
laboratory guided treatment algorithms to personalize antiplatelet medication choice after
coronary stenting